Anti-Migraine Drugs Market - Global Outlook and Forecast 2022-2028

March 2022 | 71 pages | ID: A1432FDA060DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drugs For Herpes Labialis (Oral Herpes) in global, including the following market information:

Global Drugs For Herpes Labialis (Oral Herpes) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Drugs For Herpes Labialis (Oral Herpes) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Drugs For Herpes Labialis (Oral Herpes) companies in 2021 (%)

The global Drugs For Herpes Labialis (Oral Herpes) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Valacyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drugs For Herpes Labialis (Oral Herpes) include GSK, Novartis, Teva, Mylan, Cadila, Apotex, Medivir, Livzon and Luoxin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs For Herpes Labialis (Oral Herpes) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs For Herpes Labialis (Oral Herpes) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drugs For Herpes Labialis (Oral Herpes) Market Segment Percentages, by Type, 2021 (%)

• Valacyclovir
• Aciclovir
• Famciclovir
• Docosanol
• Other

Global Drugs For Herpes Labialis (Oral Herpes) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drugs For Herpes Labialis (Oral Herpes) Market Segment Percentages, by Application, 2021 (%)

• Tablets
• Capsules

Global Drugs For Herpes Labialis (Oral Herpes) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drugs For Herpes Labialis (Oral Herpes) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs For Herpes Labialis (Oral Herpes) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Drugs For Herpes Labialis (Oral Herpes) revenues share in global market, 2021 (%)

Key companies Drugs For Herpes Labialis (Oral Herpes) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Drugs For Herpes Labialis (Oral Herpes) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Novartis
• Teva
• Mylan
• Cadila
• Apotex
• Medivir
• Livzon
• Luoxin
• Med shine
• Bayer (Campho Phenique)
• Blistex
• Kelun Group
• Hikma
• Haiwang
• Carmex
• Cipher

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Migraine Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Migraine Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-MIGRAINE DRUGS OVERALL MARKET SIZE

2.1 Global Anti-Migraine Drugs Market Size: 2021 VS 2028
2.2 Global Anti-Migraine Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-Migraine Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Anti-Migraine Drugs Players in Global Market
3.2 Top Global Anti-Migraine Drugs Companies Ranked by Revenue
3.3 Global Anti-Migraine Drugs Revenue by Companies
3.4 Global Anti-Migraine Drugs Sales by Companies
3.5 Global Anti-Migraine Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-Migraine Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-Migraine Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Migraine Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Anti-Migraine Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-Migraine Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-Migraine Drugs Market Size Markets, 2021 & 2028
  4.1.2 Triptans
  4.1.3 Ergots
  4.1.4 Others
4.2 By Type - Global Anti-Migraine Drugs Revenue & Forecasts
  4.2.1 By Type - Global Anti-Migraine Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Migraine Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-Migraine Drugs Sales & Forecasts
  4.3.1 By Type - Global Anti-Migraine Drugs Sales, 2017-2022
  4.3.2 By Type - Global Anti-Migraine Drugs Sales, 2023-2028
  4.3.3 By Type - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Anti-Migraine Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Migraine Drugs Market Size, 2021 & 2028
  5.1.2 Women
  5.1.3 Men
5.2 By Application - Global Anti-Migraine Drugs Revenue & Forecasts
  5.2.1 By Application - Global Anti-Migraine Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Migraine Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-Migraine Drugs Sales & Forecasts
  5.3.1 By Application - Global Anti-Migraine Drugs Sales, 2017-2022
  5.3.2 By Application - Global Anti-Migraine Drugs Sales, 2023-2028
  5.3.3 By Application - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Anti-Migraine Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Migraine Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-Migraine Drugs Revenue & Forecasts
  6.2.1 By Region - Global Anti-Migraine Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Migraine Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-Migraine Drugs Sales & Forecasts
  6.3.1 By Region - Global Anti-Migraine Drugs Sales, 2017-2022
  6.3.2 By Region - Global Anti-Migraine Drugs Sales, 2023-2028
  6.3.3 By Region - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Anti-Migraine Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Anti-Migraine Drugs Sales, 2017-2028
  6.4.3 US Anti-Migraine Drugs Market Size, 2017-2028
  6.4.4 Canada Anti-Migraine Drugs Market Size, 2017-2028
  6.4.5 Mexico Anti-Migraine Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Anti-Migraine Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Anti-Migraine Drugs Sales, 2017-2028
  6.5.3 Germany Anti-Migraine Drugs Market Size, 2017-2028
  6.5.4 France Anti-Migraine Drugs Market Size, 2017-2028
  6.5.5 U.K. Anti-Migraine Drugs Market Size, 2017-2028
  6.5.6 Italy Anti-Migraine Drugs Market Size, 2017-2028
  6.5.7 Russia Anti-Migraine Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Anti-Migraine Drugs Market Size, 2017-2028
  6.5.9 Benelux Anti-Migraine Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Anti-Migraine Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Anti-Migraine Drugs Sales, 2017-2028
  6.6.3 China Anti-Migraine Drugs Market Size, 2017-2028
  6.6.4 Japan Anti-Migraine Drugs Market Size, 2017-2028
  6.6.5 South Korea Anti-Migraine Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Anti-Migraine Drugs Market Size, 2017-2028
  6.6.7 India Anti-Migraine Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Anti-Migraine Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Anti-Migraine Drugs Sales, 2017-2028
  6.7.3 Brazil Anti-Migraine Drugs Market Size, 2017-2028
  6.7.4 Argentina Anti-Migraine Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-Migraine Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Anti-Migraine Drugs Sales, 2017-2028
  6.8.3 Turkey Anti-Migraine Drugs Market Size, 2017-2028
  6.8.4 Israel Anti-Migraine Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Anti-Migraine Drugs Market Size, 2017-2028
  6.8.6 UAE Anti-Migraine Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Anti-Migraine Drugs Major Product Offerings
  7.1.4 Eli Lilly Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Anti-Migraine Drugs Major Product Offerings
  7.2.4 Abbott Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Abbott Key News
7.3 Eisai
  7.3.1 Eisai Corporate Summary
  7.3.2 Eisai Business Overview
  7.3.3 Eisai Anti-Migraine Drugs Major Product Offerings
  7.3.4 Eisai Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Eisai Key News
7.4 Allergan
  7.4.1 Allergan Corporate Summary
  7.4.2 Allergan Business Overview
  7.4.3 Allergan Anti-Migraine Drugs Major Product Offerings
  7.4.4 Allergan Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Allergan Key News
7.5 Endo
  7.5.1 Endo Corporate Summary
  7.5.2 Endo Business Overview
  7.5.3 Endo Anti-Migraine Drugs Major Product Offerings
  7.5.4 Endo Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Endo Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Anti-Migraine Drugs Major Product Offerings
  7.6.4 GlaxoSmithKline Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Impax Laboratories
  7.7.1 Impax Laboratories Corporate Summary
  7.7.2 Impax Laboratories Business Overview
  7.7.3 Impax Laboratories Anti-Migraine Drugs Major Product Offerings
  7.7.4 Impax Laboratories Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Impax Laboratories Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Anti-Migraine Drugs Major Product Offerings
  7.8.4 Pfizer Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Pfizer Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Anti-Migraine Drugs Major Product Offerings
  7.9.4 AstraZeneca Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 Bayer
  7.10.1 Bayer Corporate Summary
  7.10.2 Bayer Business Overview
  7.10.3 Bayer Anti-Migraine Drugs Major Product Offerings
  7.10.4 Bayer Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Bayer Key News
7.11 Johnson & Johnson
  7.11.1 Johnson & Johnson Corporate Summary
  7.11.2 Johnson & Johnson Anti-Migraine Drugs Business Overview
  7.11.3 Johnson & Johnson Anti-Migraine Drugs Major Product Offerings
  7.11.4 Johnson & Johnson Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.11.5 Johnson & Johnson Key News
7.12 Merck
  7.12.1 Merck Corporate Summary
  7.12.2 Merck Anti-Migraine Drugs Business Overview
  7.12.3 Merck Anti-Migraine Drugs Major Product Offerings
  7.12.4 Merck Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.12.5 Merck Key News
7.13 Teva
  7.13.1 Teva Corporate Summary
  7.13.2 Teva Anti-Migraine Drugs Business Overview
  7.13.3 Teva Anti-Migraine Drugs Major Product Offerings
  7.13.4 Teva Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.13.5 Teva Key News
7.14 Amgen
  7.14.1 Amgen Corporate Summary
  7.14.2 Amgen Business Overview
  7.14.3 Amgen Anti-Migraine Drugs Major Product Offerings
  7.14.4 Amgen Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
  7.14.5 Amgen Key News

8 GLOBAL ANTI-MIGRAINE DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-Migraine Drugs Production Capacity, 2017-2028
8.2 Anti-Migraine Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Migraine Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-MIGRAINE DRUGS SUPPLY CHAIN ANALYSIS

10.1 Anti-Migraine Drugs Industry Value Chain
10.2 Anti-Migraine Drugs Upstream Market
10.3 Anti-Migraine Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-Migraine Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Anti-Migraine Drugs in Global Market
Table 2. Top Anti-Migraine Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-Migraine Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-Migraine Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Anti-Migraine Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-Migraine Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-Migraine Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Anti-Migraine Drugs Product Type
Table 9. List of Global Tier 1 Anti-Migraine Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Migraine Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Migraine Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-Migraine Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-Migraine Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-Migraine Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-Migraine Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Anti-Migraine Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-Migraine Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-Migraine Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-Migraine Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-Migraine Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Anti-Migraine Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-Migraine Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-Migraine Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-Migraine Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-Migraine Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Anti-Migraine Drugs Product Offerings
Table 48. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Abbott Corporate Summary
Table 50. Abbott Anti-Migraine Drugs Product Offerings
Table 51. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Eisai Corporate Summary
Table 53. Eisai Anti-Migraine Drugs Product Offerings
Table 54. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Allergan Corporate Summary
Table 56. Allergan Anti-Migraine Drugs Product Offerings
Table 57. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Endo Corporate Summary
Table 59. Endo Anti-Migraine Drugs Product Offerings
Table 60. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Anti-Migraine Drugs Product Offerings
Table 63. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Impax Laboratories Corporate Summary
Table 65. Impax Laboratories Anti-Migraine Drugs Product Offerings
Table 66. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Anti-Migraine Drugs Product Offerings
Table 69. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. AstraZeneca Corporate Summary
Table 71. AstraZeneca Anti-Migraine Drugs Product Offerings
Table 72. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Bayer Corporate Summary
Table 74. Bayer Anti-Migraine Drugs Product Offerings
Table 75. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Johnson & Johnson Corporate Summary
Table 77. Johnson & Johnson Anti-Migraine Drugs Product Offerings
Table 78. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Merck Corporate Summary
Table 80. Merck Anti-Migraine Drugs Product Offerings
Table 81. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Teva Corporate Summary
Table 83. Teva Anti-Migraine Drugs Product Offerings
Table 84. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Amgen Corporate Summary
Table 86. Amgen Anti-Migraine Drugs Product Offerings
Table 87. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Anti-Migraine Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Anti-Migraine Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Anti-Migraine Drugs Production by Region, 2017-2022 (K Units)
Table 91. Global Anti-Migraine Drugs Production by Region, 2023-2028 (K Units)
Table 92. Anti-Migraine Drugs Market Opportunities & Trends in Global Market
Table 93. Anti-Migraine Drugs Market Drivers in Global Market
Table 94. Anti-Migraine Drugs Market Restraints in Global Market
Table 95. Anti-Migraine Drugs Raw Materials
Table 96. Anti-Migraine Drugs Raw Materials Suppliers in Global Market
Table 97. Typical Anti-Migraine Drugs Downstream
Table 98. Anti-Migraine Drugs Downstream Clients in Global Market
Table 99. Anti-Migraine Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Migraine Drugs Segment by Type
Figure 2. Anti-Migraine Drugs Segment by Application
Figure 3. Global Anti-Migraine Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Migraine Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Migraine Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-Migraine Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Migraine Drugs Revenue in 2021
Figure 9. By Type - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-Migraine Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-Migraine Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 19. US Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 24. Germany Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 33. China Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-Migraine Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-Migraine Drugs by Region, 2021 VS 2028
Figure 50. Anti-Migraine Drugs Industry Value Chain
Figure 51. Marketing Channels